Cargando…
Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations
Autores principales: | Kingston, Belinda, Bailleux, Caroline, Delaloge, Suzette, Schiavon, Gaia, Scott, Veronique, Lacroix-Triki, Magali, Carr, T. Hedley, Kozarewa, Iwanka, Gevensleben, Heidrun, Kemp, Zoe, Pearson, Alex, Turner, Nicholas, André, Fabrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446515/ https://www.ncbi.nlm.nih.gov/pubmed/32923864 http://dx.doi.org/10.1200/PO.19.00130 |
Ejemplares similares
-
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations
por: Rodón, Jordi, et al.
Publicado: (2022) -
Germline PTEN mutations are rare and highly penetrant
por: Rustad, Cecilie F, et al.
Publicado: (2006) -
Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of GC-biased genomes
por: Kozarewa, Iwanka, et al.
Publicado: (2009) -
Small cell osteosarcoma of the rib: An exceptional localization
por: Abid, Walid, et al.
Publicado: (2022) -
Whole Genome Sequencing Highlights Genetic Changes Associated with Laboratory Domestication of C. elegans
por: Weber, Katherine P., et al.
Publicado: (2010)